Tandem Diabetes Care Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 2,400

Employees

  • Stock Symbol
  • TNDM

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $31.91
  • (As of Friday Closing)

Tandem Diabetes Care General Information

Description

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 12400 High Bluff Drive
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 12400 High Bluff Drive
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tandem Diabetes Care Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$31.91 $31.37 $13.82 - $53.69 $2.09B 65.5M 1.29M -$2.10

Tandem Diabetes Care Financials Summary

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 2,612,051 1,848,955 2,703,519 9,283,924
Revenue 796,002 747,718 801,217 702,799
EBITDA (112,622) (219,832) (80,266) 33,385
Net Income (136,492) (222,611) (94,594) 15,566
Total Assets 937,503 952,658 1,052,785 905,137
Total Debt 477,114 415,667 419,877 314,668
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tandem Diabetes Care Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tandem Diabetes Care‘s full profile, request access.

Request a free trial

Tandem Diabetes Care Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Tandem Diabetes Care‘s full profile, request access.

Request a free trial

Tandem Diabetes Care Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered t
Monitoring Equipment
San Diego, CA
2,400 As of 2023

San Diego, CA
 

East Brisbane, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tandem Diabetes Care Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DexCom Formerly VC-backed San Diego, CA
Ellume Formerly VC-backed East Brisbane, Australia
POGO Automatic Private Equity-Backed Fremont, CA
Jana Care Venture Capital-Backed Watertown, MA
Medtronic Dental Corporate Backed or Acquired Weilrod, Germany
You’re viewing 5 of 5 competitors. Get the full list »

Tandem Diabetes Care Patents

Tandem Diabetes Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240226423-A1 User-wearable infusion pump system Pending 09-Jan-2023
US-20240226424-A1 Applicator device for user-wearable infusion pump Pending 09-Jan-2023
US-20240050650-A1 Ambulatory infusion pump system including pump holder Pending 11-Aug-2022
US-20240189504-A1 Insulin pump with integrated continuous glucose monitor Pending 08-Jul-2022
US-20230381406-A1 Filter for infusion pump systems Pending 24-May-2022 A61M5/14244
To view Tandem Diabetes Care’s complete patent history, request access »

Tandem Diabetes Care Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tandem Diabetes Care Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sigi (Therapeutic Devices) 23-Jan-2023 Therapeutic Devices
Capillary Biomedical 21-Jul-2022 Therapeutic Devices
CeQur Simplicity 13-Apr-2021 Therapeutic Devices
Sugarmate 24-Jun-2020 Other Healthcare Technology Systems
Smiths Medical (Patents and Patent Applications) 01-Feb-2013 Corporate Asset Purchase Buildings and Property
To view Tandem Diabetes Care’s complete investments and acquisitions history, request access »

Tandem Diabetes Care Subsidiaries (1)

Company Name Industry Location Founded
Sugarmate Other Healthcare Technology Systems San Diego, CA
To view Tandem Diabetes Care’s complete subsidiaries history, request access »

Tandem Diabetes Care ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

34.83 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,009

Rank

Percentile

Healthcare

Industry

of 634

Rank

Percentile

Medical Devices

Subindustry

of 225

Rank

Percentile

To view Tandem Diabetes Care’s complete esg history, request access »

Tandem Diabetes Care FAQs

  • When was Tandem Diabetes Care founded?

    Tandem Diabetes Care was founded in 2006.

  • Where is Tandem Diabetes Care headquartered?

    Tandem Diabetes Care is headquartered in San Diego, CA.

  • What is the size of Tandem Diabetes Care?

    Tandem Diabetes Care has 2,400 total employees.

  • What industry is Tandem Diabetes Care in?

    Tandem Diabetes Care’s primary industry is Monitoring Equipment.

  • Is Tandem Diabetes Care a private or public company?

    Tandem Diabetes Care is a Public company.

  • What is Tandem Diabetes Care’s stock symbol?

    The ticker symbol for Tandem Diabetes Care is TNDM.

  • What is the current stock price of Tandem Diabetes Care?

    As of 01-Nov-2024 the stock price of Tandem Diabetes Care is $31.91.

  • What is the current market cap of Tandem Diabetes Care?

    The current market capitalization of Tandem Diabetes Care is $2.09B.

  • What is Tandem Diabetes Care’s current revenue?

    The trailing twelve month revenue for Tandem Diabetes Care is $796M.

  • Who are Tandem Diabetes Care’s competitors?

    DexCom, Ellume, POGO Automatic, Jana Care, and Medtronic Dental are competitors of Tandem Diabetes Care.

  • What is Tandem Diabetes Care’s annual earnings per share (EPS)?

    Tandem Diabetes Care’s EPS for 12 months was -$2.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »